IVIG for MIS-C Works by Depleting Inflammatory Immune Cells

By Marie Rosenthal

Intravenous immune globulin (IVIG)—a common treatment for multisystem inflammatory syndrome in children (MIS-C)—likely works by depleting neutrophils, according to a recent study from the University of California, San Diego.